Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lee S. Schwartzberg, MD, FACP
The West Clinic
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hematology Oncology Pc
Stamford, Connecticut, United States
- Central Georgia Cancer Care
Macon, Georgia, United States
- Northwest Georgia Oncology Centers
Marietta, Georgia, United States
- North Shore Cancer Research
Skokie, Illinois, United States
- Hematology Oncology Associates of the Quad Cities
Bettendorf, Iowa, United States
- Baystate Medical Center
Springfield, Massachusetts, United States
- Hematology Oncology Centers of the Northern Rockies
Billings, Montana, United States
- Oncology Hematology Specialists, P.A.
Denville, New Jersey, United States
- the Moses H. Cone Regional Cancer Center
Greensboro, North Carolina, United States
- North Coast Cancer Care
Sandusky, Ohio, United States
- Pennsylvania Oncology Hematology Associates
Philadelphia, Pennsylvania, United States
- the West Clinic
Memphis, Tennessee, United States
- University of Tennessee Cancer Institute
Memphis, Tennessee, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2009
- Primary completion
- 31 Oct 2013
- Completion
- 31 Oct 2013
- Last update posted
- 13 Oct 2014
- Registered enrollment
- 56
- Registry id
- NCT00924352
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.